Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review.

Dick, Maurice H; Abdelgadir, Arowa; Kulkarni, Vaishnavi Vijaya; Akram, Hamna; Chatterjee, Abanti; Pokhrel, Sushil; Khan, Safeera

Dick, Maurice H; Abdelgadir, Arowa; Kulkarni, Vaishnavi Vijaya; Akram, Hamna; Chatterjee, Abanti; Pokhrel, Sushil; Khan, Safeera.

Afiliação

Dick MH; Medical School, Saint James School of Medicine, Arnos Vale, VCT.
Abdelgadir A; Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Kulkarni VV; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Akram H; Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Chatterjee A; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Pokhrel S; Plastic Surgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Khan S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus ; 14(5): e24920, 2022 May.

Article em En | MEDLINE | ID: mdl-35706735